Yong-qing Wang

300 Guangzhou Road, 210029
Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Ginsenosides remodel tumor immune microenvironment through metabolic reprogramming: Targets and mechanisms.

Ginsenosides remodel tumor immune microenvironment through metabolic reprogramming: Targets and mechanisms.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: December 01, 2025

Zanubrutinib in B-cell lymphomas: from clinical pharmacology to therapeutic application.

Zanubrutinib in B-cell lymphomas: from clinical pharmacology to therapeutic application.

Journal: European journal of clinical pharmacology

Published: October 05, 2025

Simultaneous Determination of Ripretinib and Its Desmethyl Metabolite in Human Plasma Using LC-MS/MS.

Simultaneous Determination of Ripretinib and Its Desmethyl Metabolite in Human Plasma Using LC-MS/MS.

Journal: Therapeutic drug monitoring

Published: January 21, 2024

Safety, pharmacokinetics, and food-effect of pivmecillinam after single- and multiple-dose in healthy Chinese subjects: a phase I study.

Safety, pharmacokinetics, and food-effect of pivmecillinam after single- and multiple-dose in healthy Chinese subjects: a phase I study.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: January 12, 2024

Determination of caffeine, paraxanthine, theophylline and theobromine in premature infants by HILIC-MS/MS.

Determination of caffeine, paraxanthine, theophylline and theobromine in premature infants by HILIC-MS/MS.

Journal: Bioanalysis

Published: February 24, 2023

LC-MS/MS methods for determination of venetoclax in human plasma and cerebrospinal fluid.

LC-MS/MS methods for determination of venetoclax in human plasma and cerebrospinal fluid.

Journal: Biomedical chromatography : BMC

Published: February 24, 2023

Simultaneous Determination of Ibrutinib, Dihydroxydiol Ibrutinib, and Zanubrutinib in Human Plasma by Liquid Chromatography-Mass Spectrometry/Mass Spectrometry.

Simultaneous Determination of Ibrutinib, Dihydroxydiol Ibrutinib, and Zanubrutinib in Human Plasma by Liquid Chromatography-Mass Spectrometry/Mass Spectrometry.

Journal: Therapeutic drug monitoring

Published: January 10, 2023

Simultaneous Determination of Orelabrutinib, Zanubrutinib, Ibrutinib and Its Active Metabolite in Human Plasma Using LC-MS/MS.

Simultaneous Determination of Orelabrutinib, Zanubrutinib, Ibrutinib and Its Active Metabolite in Human Plasma Using LC-MS/MS.

Journal: Molecules (Basel, Switzerland)

Published: November 15, 2022

Determination of Orelabrutinib in Human Plasma Using LC-MS/MS.

Determination of Orelabrutinib in Human Plasma Using LC-MS/MS.

Journal: Therapeutic drug monitoring

Published: October 06, 2022

LC-MS/MS methods to quantify HCP002 in human plasma and urine: applications in a pharmacokinetic study.

LC-MS/MS methods to quantify HCP002 in human plasma and urine: applications in a pharmacokinetic study.

Journal: Bioanalysis

Published: February 23, 2022

LC-MS/MS methods for determination of unstable pivmecillinam and mecillinam in acidified human plasma: Application to a pharmacokinetic study.

LC-MS/MS methods for determination of unstable pivmecillinam and mecillinam in acidified human plasma: Application to a pharmacokinetic study.

Journal: Journal of separation science

Published: February 04, 2022

Development and validation of a hydrophilic interaction liquid chromatography-tandem mass spectrometry method for the quantification of regadenoson in human plasma and its pharmacokinetic application.

Development and validation of a hydrophilic interaction liquid chromatography-tandem mass spectrometry method for the quantification of regadenoson in human plasma and its pharmacokinetic application.

Journal: Journal of separation science

Published: September 18, 2021

Showing 1-12 of 37

Last Updated: 09/26/2026